Related Experiment Video
Updated: Apr 16, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
[Haemostasis dysregulation in filovirus infections]
Olivier Reynard1, Beatriz Escudero-Perez1, Viktor Volchkov1
1CIRI (centre international de recherche en infectiologie), Inserm U1111, laboratoire bases moléculaires de la pathogénicité virale, 21, avenue Tony Garnier, 69007 Lyon, France.
Abstract:
Filoviruses are responsible for highly lethal infections. Those viruses are found in intertropical areas of Africa and Asia where they circulate in their supposed natural reservoir, fruit bats. During filovirus outbreaks and depending on the strains, various modifications in hemostasis have been observed in patients. The disseminated intravascular coagulation identified in these infections is multicausal and involves both viral factors and abnormal physiological responses. In this review we will describe the mechanisms responsible for these disturbances and we will highlight some aspects of the basis of filovirus high pathogenicity.
Insights
Filoviruses cause lethal infections, affecting hemostasis through viral and physiological factors. This review details the mechanisms behind these disturbances and filovirus pathogenicity.
Area of Science:
- * Virology and Pathogenisis
- * Hematology and Coagulation Disorders
Background:
- * Filoviruses, including Ebola and Marburg viruses, are known for causing severe, often fatal hemorrhagic fevers.
- * These viruses are endemic to tropical regions of Africa and Asia, with fruit bats suspected as their natural reservoir.
- * Clinical manifestations during filovirus outbreaks frequently involve significant hemostatic abnormalities.
Purpose of the Study:
- * To elucidate the complex mechanisms underlying hemostatic disturbances during filovirus infections.
- * To explore the multifactorial nature of disseminated intravascular coagulation (DIC) in these patients.
- * To highlight key factors contributing to the high pathogenicity of filoviruses.
Main Methods:
- * Comprehensive literature review of studies on filovirus outbreaks and associated hemostatic changes.
- * Analysis of viral factors and host physiological responses implicated in coagulation disorders.
- * Synthesis of current understanding regarding filovirus pathogenesis and disease severity.
Main Results:
- * Filovirus infections trigger a complex coagulopathy, often presenting as disseminated intravascular coagulation (DIC).
- * DIC in filovirus infections is multifactorial, resulting from interactions between viral components and the host's immune and physiological responses.
- * Specific viral proteins and the host's inflammatory cascade play critical roles in disrupting normal hemostasis.
Conclusions:
- * Understanding the mechanisms of hemostasis disruption is crucial for managing filovirus infections.
- * The interplay between viral factors and host responses significantly contributes to the severe pathogenicity of filoviruses.
- * Further research into these mechanisms may reveal therapeutic targets to mitigate filovirus-induced coagulopathy and improve patient outcomes.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care